SCHEMBL21052209

SCHEMBL21052209

O=C(O)Nc1ccc(F)cc1-c1cccs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.48
SMN1; SMN2 Q16637 5/20 0.48
TP53 P04637 2/20 0.48
GAA P10253 1/20 0.48
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
ALDH1A1 P00352 4/20 0.45
MAPT P10636 4/20 0.45
KDM4E B2RXH2 3/20 0.45
RXFP1 Q9HBX9 2/20 0.44
PTGER2 P43116 1/20 0.44
STK33 Q9BYT3 1/20 0.42
NPC1 O15118 3/20 0.41
TNFRSF1A P19438 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
ABL1 P00519 1/20 0.40
BCR P11274 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CACNA1B Q00975 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21088466 0.85 RAB9A (0.43) RAB9ASMN1; SMN2TP53GAAMEN1
SCHEMBL4325551 0.80 HCRTR1 (0.48) RAB9ASMN1; SMN2TP53GAAMEN1
SCHEMBL21087778 0.78 MAPT (0.42) RAB9ASMN1; SMN2TP53GAAMEN1
SCHEMBL21052182 0.78 MAPT (0.39) RAB9ASMN1; SMN2TP53GAAMEN1
SCHEMBL21052234 0.77 ABL1 (0.39) RAB9ASMN1; SMN2TP53MAPTSTK33
SCHEMBL21052242 0.77 RXFP1 (0.57) MEN1KMT2AMAPTKDM4ERXFP1
SCHEMBL21052202 0.77 TP53 (0.41) RAB9ASMN1; SMN2TP53GAAALDH1A1
SCHEMBL3906763 0.76 MAPT (0.56) RAB9ASMN1; SMN2TP53ALDH1A1MAPT
SCHEMBL21052166 0.75 CSF1R (0.41) RAB9ATP53GAAMEN1KMT2A
SCHEMBL16438520 0.74 CHRM3 (0.50) MAPTHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3720852-A1 FLUOROPHENYL SUBSTITUTED MUSCARINIC RECEPTOR LIGANDS WITH SELECTIVITY FOR M3 OVER M2 Friedrich-Alexander-Universität Erlangen-Nürnberg (DE) 2020-10-14 EP claimed
US-20200308168-A1 FLUOROPHENYL SUBSTITUTED MUSCARINIC RECEPTOR LIGANDS WITH SELECTIVITY FOR M3 OVER M2 Friedrich-Alexander-Universität Erlangen-Nürnberg (DE) 2020-10-01 US claimed
WO-2019110521-A1 FLUOROPHENYL SUBSTITUTED MUSCARINIC RECEPTOR LIGANDS WITH SELECTIVITY FOR M3 OVER M2 Friedrich-Alexander-Universität Erlangen-Nürnberg (DE) 2019-06-13 WO claimed
EP-3720852-A1 FLUOROPHENYL SUBSTITUTED MUSCARINIC RECEPTOR LIGANDS WITH SELECTIVITY FOR M3 OVER M2 Friedrich-Alexander-Universität Erlangen-Nürnberg (DE) 2020-10-14 EP disclosed
US-20200308168-A1 FLUOROPHENYL SUBSTITUTED MUSCARINIC RECEPTOR LIGANDS WITH SELECTIVITY FOR M3 OVER M2 Friedrich-Alexander-Universität Erlangen-Nürnberg (DE) 2020-10-01 US disclosed
WO-2019110521-A1 FLUOROPHENYL SUBSTITUTED MUSCARINIC RECEPTOR LIGANDS WITH SELECTIVITY FOR M3 OVER M2 Friedrich-Alexander-Universität Erlangen-Nürnberg (DE) 2019-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200308168-A1 FLUOROPHENYL SUBSTITUTED MUSCARINIC RECEPTOR LIGANDS WITH SELECTIVITY FOR M3 OVER M2 CHRM2, CHRM3, CHRM5 RAB9A 3359/4885SMN1; SMN2 1439/4885TP53 1551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.